The neuroprotective role of estrogen (E 2 ) is supported by a multitude of experimental and epidemiological data, although its mode of action is not fully understood. The present work was conducted to study the underlying mechanisms of its neuroprotective action, using the rat cell line PC12, an established model for neuronal cell apoptosis and survival. Our results show that E 2 (but not androgens or progestins) prevent growth inhibition and apoptosis of PC12 cells, induced by serum deprivation. Several mechanisms of action were investigated: 1) intracellular estrogen receptors (ERs) have been identified but do not appear to mediate the protective effect of E 2 .
species leakage. In addition, lipid peroxidation is an important target of pro-oxidant cell effect. In this respect, E 2 was found to induce neural cell protection from a number of prooxidant stimuli, including H 2 O 2 and superoxide anions. Although clearly documented, this E 2 -antioxidant effect needs elevated, supraphysiological concentrations (reviewed in ref 1) and cannot explain their action at physiological ones. 3) E 2 can also act through a membrane binding component. Its existence has been postulated for 20 years, although there are controversies about its nature (reviewed in refs 6, 7, 8) . Experimental evidence suggests that this membrane binding component may be as follows: 1) a true binding site, distinct from intracellular ER. Evidence for a distinct site include a specific G-protein coupled receptor (GPCR)-modifying agents and effectors susceptibility (reviewed in ref 9) or other growth factor receptors, including EGFR (10) . Alternatively, activation of a putative membrane receptor, a transactivation of GPCRs at the plasma membrane level can occur, leading to their activation or repression, via Ca 2+ mobilization, and subsequent activation of a number of kinases (11, 12) . 2) An alternative explanation has been advanced to explain membrane effects of E 2 , involving the anchorage of conventional ER on the plasma membrane, either through posttranslational modifications (e.g., palmitolation/myristolation) or through interaction with a number of unknown integrated membrane proteins (reviewed in ref 13) . Such proteins are tissue-and cell-type specific, having molecular masses between 20 and 160 kDa (reviewed in ref 13 ).
It appears therefore that the mode of action of E 2 in neural cells remains still speculative and has a long way to being understood. We have thus studied the potential mechanism of neuroprotective action of E 2 , using the well-characterized rat PC12 cell line, an established model to study growth factor deprivation-induced cell apoptosis and survival (14) . In the present study, we provide evidence that these cells express both intracellular and membrane estrogen binding sites. The presence of intracellular ER in PC12 cells is controversial, and both positive (15) and negative results (16) (17) (18) (19) have been reported. In addition, we report that E 2 can induce cell survival through interaction with estrogen membrane sites and downstream activation of the Akt/NOS system.
MATERIALS AND METHODS

Cell cultures
The PC12 cell line, originally isolated from a transplantable rat adrenal pheochromocytoma, was obtained from Dr. M. Greenberg (Children's Hospital, Boston, MA). They are cultured in RPMI 1640 medium at 37°C and 5% CO 2 in the presence of 10% fetal bovine serum (FBS) and 5% horse serum. Cells were subcultured weekly with trypsinization (by using trypsin/EDTA). All culture media were purchased from Gibco-BRL (Life Technologies, Paisley, UK). PC12 cells were maintained for 2 days in complete media, supplemented with charcoal-stripped serum. On day 0 of each experiment, complete medium was changed either with complete (serum supplemented) or with serum-free medium containing 0.1% bovine serum albumin (BSA) fraction V. Steroid (estradiol, progesterone, testosterone) purchases from Steraloids (Newport, RI), ICI 182780 (Tocris, Bristol, UK), or BSA bound estradiol (10 molecules E 2 per molecule of BSA, Sigma, St Louis, MO) was added at this stage, dissolved in the appropriate culture medium, and culture was continued for the specific time-intervals, as described in Results. In the case of E 2 -BSA, before each experiment, stock solutions of BSA-conjugates were mixed with dextran (0.05 mg/ml) and charcoal (50 mg/ml) for 30 min (DCC treatment) centrifuged at 3000 g for l0 min and passed through a 0.22 mm filter to remove any potential contamination with free estradiol. In that case too, we assayed the medium for the presence of free estradiol with a specific radioimmunoassay method. In all cases, E 2 was lower than the detection limit of the assay.
Quantitative measurement of apoptosis in PC12 cells
Apoptosis in PC12 cells was assayed using three different methods.
The APOPercentage Apoptosis Assay (Biocolor Ltd., Belfast, N. Ireland) was used to quantify apoptosis. The assay uses a dye that stains red the apoptotic cells undergoing the membrane "flip-flop" event when phosphatidylserine is translocated to the outer leaflet. Detection of apoptosis can be readily observed under inverted microscopy. For apoptosis quantitation, the amount of dye within the labeled cells can subsequently be released into solution and the concentration is measured at a wavelength of 550 nm, using a color filter microplate colorimeter (Dynatech MicroElisa reader Chantilly, VA).
The cell death detection ELISA kit (Roche Diagnostics, Mannheim, Germany) was used, based on a quantitative measurement of DNA and histones. Apoptosis is characterized by activation of endogenous endonucleases that cleave double stranded DNA at the most accessible internucleosomal linker region, generating mono-and oligonucleosomes in the cytoplasmic fraction of cell lysates. The cytoplasm of cell-lysate is placed into a streptavidin-coated 96-well plate. Anti-histone-biotin and anti-DNA-POD are added and incubated for 2 h in room temperature. The anti-histone antibody binds to the histone-component of the nucleosomes and captures the immunocomplex to streptavidin by biotinylation, while the anti-DNA-POD antibody reacts with the DNA-component of the nucleosomes. The photometrical (measurement at 405 nm, reference wavelength at 490 nm) determination of POD with ABTS as substrate allows the quantitative determination of nucleosomes.
Flow cytometry of annexin V-propidium iodide-stained cells was also used. Cells were transferred to a staining tube and washed with 4 ml of PBS, containing 1% BSA, at 4°C. After medium removal (200 rpm, 10 min, 4°C), 100 µl of a 2 µg/ml annexin-V-FITC were added, in a staining buffer (10 mM HEPES, 140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 2.5 mM CaCl 2 , pH 7.4), and incubated for 10 min in the dark. Then, 1 µg/tube of propidium iodide was added, and cells were analyzed within 20 min by flow cytometry, using a Beckton-Dickinson FACSArray apparatus (Beckton-Dickinson, Franklin Lakes, NJ) and analyzed with the CELLQuest (BecktonDickinson) and ModFit LT (Verify Software, Topsham, MN) software.
Detection of intracellular steroid receptors in PC12 cells
PC12 ells (150×10
3 ) were seeded in 24-well culture dishes. After 24 h, medium was aspirated, and cells were washed with phosphate buffered saline. Binding was performed on whole cells, in serum-free phosphate buffered saline, in a total volume of 0.4 ml. For displacement binding of [ 3 H]estradiol (New England Nuclear, Zaventum, Belgium, specific activity 103 Ci/mmol) was introduced at a concentration of 1.09 nM (~40,000 cpm) in PBS, together with varying concentrations of nonlabeled steroids, varying from 10 −12 to 10 −6 M. Nonspecific binding was estimated by the addition of 10 −5 M of estradiol (Sigma). After overnight incubation at 4°C, under agitation, medium was aspirated, cells were washed twice with 1.0 ml ice-cold PBS, removed from plates with 1 ml 0.5 N NaOH, and mixed with 5 ml scintillation cocktail (SigmaFluor, Sigma). The bound radioactivity was counted in a scintillation counter (Perkin Elmer, Foster City, CA), with 60% efficiency for Tritium. Binding was repeated at least three times (in duplicate). The results were analyzed by the Origin (MicroCal Co., Northampton, MA) V.5 package, using equations described by Munson and Rodbard (20) .
Assay for Ah receptor binding and CYP1A1 activity
PC12 cells were plated in 24-well culture dishes (with an initial density of 150x10 3 cells/well). When the cell culture reached ~70-80% confluency, Ah receptor binding was performed in serum-free RPMI medium in a total volume of 0.4 ml. [ 3 H]TCDD (34.7 Ci/mmol, ChemSyn Laboratories) was used in a final concentration 5 nM, diluted in DMSO, while a 200-fold molar excess of unlabeled TCDD (Wellington Laboratories, Greyhound, UK) was used for nonspecific binding estimation. After 2 h incubation at 37°C in a 5% CO 2 atmosphere, the medium was removed and cells were washed once with ice-cold PBS containing 10% fetal calf serum (FBS) and afterwards once with cold PBS. Cells were then detached from dishes with 0.1 ml trypsin/EDTA, and filtered on Whatman GF/B glass fiber filters (1.0 µm), prewetted in cold PBS (4°C). The filters were then washed with cold (-80°C) acetone, allowed to dry and the radioactivity was measured in 3 ml scintillation cocktail (SigmaFluor, Sigma) by using a liquid scintillation counter (Tricarb, Packard, Instrument Co., Meriden, CT) with 60% efficiency for tritium. All measurements were performed in triplicate (21, 22) .
The activity of CYP1A1 and the combined CYP1A1/1A2 activity, enzymes induced by AhR activation, was assayed by the O-dealkylation of ethoxy-and methoxyresorufin (EROD and MROD, respectively; ref 22; Molecular Probes, Leiden, The Netherlands). PC12 cells were cultured in a black, clear bottom, 96-well plate. When they have reached 50-60% confluency, 5 nM of TCDD were added, diluted in DMSO. Blank, control, and assay wells received the same amount of DMSO. After a 24 h incubation at 37°C in an atmosphere of 95% air and 5% CO 2 , medium was removed and the plates were frozen sequentially at -20°C, dry ice, and at -80°C. Afterwards, cells were thawed at room temperature for 10 min, and BSA (diluted in 50 mM Tris pH 7.2) was added at a final concentration 1.33 µg/ml. Ethoxyresorufin (diluted in 1.5% methanol in 50 mM Tris, pH 7.2) was added at a final concentration of 5 µΜ. The plates were placed on a plate shaker at 37°C for 15 min. The EROD reaction was initiated by adding 1.67 mM NADPH in 25 µl 50 mM Tris pH 7.2. The reaction was carried out at room temperature for 7 min and stopped by adding 150 µl ice-cold methanol. The plates were allowed to sit, in room temperature, for 20-30 min before measuring. Fluoerescence was measured at 530 nm excitation wavelength and 590 nm emission wavelength with a Microplate Fluorescence Reader FL X 800 (Bio-Tech Instruments Inc.). Results were calculated against a standard curve of resorufin concentration ranging from 0 to 500 nM (Molecular Probes), diluted in methanol (21) .
Detection of membrane estrogen receptors in PC12 cells
Binding assays
Membrane preparation-PC12 cells were cultured in 225 cm 2 flasks and, after being washed twice with PBS, they were detached from the flasks by vigorous shaking. Trypsinization of cells was avoided to preserve any membrane binding site integrity. After a centrifugation at 1500 g, cells were homogenized by sonication in a 50 mM Tris-HCl buffer, pH 7.4 (at 4°C), containing freshly added protease inhibitors (1 mM PMSF and 1 µg/ml apoprotin). Membrane fraction was prepared by differential centrigufation at 2500 g (15 min), and 103,000 g (1 h) at 4°C. Membranes were washed once with Tris-HCl, briefly acidified to remove any bound intracellular ER (23) , and resuspeded to the same buffer at a protein concentration of 2 mg/ml.
Binding conditions-Membranes (2 mg/ml) were incubated with 5 nM [
3 H]estradiol in the presence or absence of 1000-fold molar excess of an unlabeled analog (Diethylsilvestrol), in a final volume of 100 µl. After an overnight incubation at 4°C on a shaker, membranes were collected on GF/B filters, prewetted in 0.5% PEI solution at 4°C. Filters were washed three times with ice-cold 50 mM Tris-HCl, pH 7.4, dried, and counted in a scintillation counter (Perkin Elmer, Foster City, CA) with 60% efficiency for Tritium. Dihydrotestosterone and ORG2058 (Sigma, St Louis, MO) were used, in displacement binding, at concentrations varying from 10
to 10 −6 M, for estimation of a possible interaction of androgens and progestins on this site.
Flow cytometry (FACS)
PC12 cells were removed from the culture flasks by shaking and suspended in PBS at a density of 10 6 cells/ml. They were preincubated 10 min with 10 
Confocal laser microscopy
PC12 cells were allowed to grow on poly-L-lysine coated glass coverslips for 24 h in culture medium and then for 24 h in serum-free medium. Afterwards the medium was aspirated and cells were washed twice with PBS. Blocking conditions were attained by incubation for 15 min at room temperature with 1% gelatin solution (in PBS), which was followed by a brief wash (four times) with PBS. Cells were incubated with either BSA-FITC, or estradiol-BSA-FITC for 30 min at 37°C in the dark, washed with PBS, and fixed with 4% formaldehyde (diluted in PBS) for 15 min at room temperature. Coverslips were mounted on to slides with an antifade fluid (Flukafrom BioChemica). Specimens were analyzed by using a confocal laser scanning microscope (CLSM; Leica TCS-NT).
Measurement of intracellular Ca
2+
PC12 cells were detached from the culture flasks by trypsinization and vigorous shaking, washed, and resuspended in Ca 2+ medium (140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 2 mM 
Assay of nitric oxide synthase activity
Nitric oxide synthase (NOS) activity was assayed, by the transformation of radioactive arginine to citrulline (24, 25) . Briefly, PC12 cells cells were detached from dishes by trypsin-EDTA, washed with phosphate-buffered saline (PBS), harvested in PBS-1mM EDTA, and homogenized with repeated pipetting with 250 µl homogenization buffer (250 mM Tris, 10 mM EDTA, 10 mM EGTA, pH 7.4). Nuclei and unbroken cells were separated by centrifugation at 12,000 g for 15 min, and discarded, while the supernatant was used for the assay of NOS. The concentration of proteins was adjusted at 10 µg/ml. A reaction mixture (sufficient for 10 data points) was prepared, with 250 µl of 50 mM Tris-HCl pH 7.4 containing 6 µM tetrahydrobiopterin, 2 µM flavin adenine dinucleotide and 2 µM flavin adenine mononucleotide, 50 µl of 10 mM NADPH, 10 µl [ 3 H]arginine (Amersham, Buckinghamshire, UK), 50 µl of 6 mM CaCl 2 , and 40 µl distilled water. Forty microliters of this reaction mixture were mixed with 10 µl of the protein extract and incubated for 1 h at 37°C. During this incubation time, [ 3 H]arginine is converted by NOS to [ 3 H]citrulline. The reaction was stopped with 400 µl of ice-cold 50 mM HEPES (pH 5.5)-5 mM EDTA. Nonreacted arginine was eliminated by resin absorption (AG 50Wx*, Bio-Rad Laboratories, Hercules, CA). The eluate was mixed with scintillation fluid (SigmaFluor, Sigma), and the radioactivity was measured in a liquid scintillation counter (Perkin Elmer, Foster City, CA), with 60% efficiency for tritium.
Detection of reactive oxygen species
Reactive oxygen species (ROS) production was assayed by flow cytometry, as described by Rothe and Valet (26) . Briefly, 1,000,000 PC12 cells, incubated for 24 h in the presence or the absence of serum were loaded with dihydroxyrhodamine 123 (Molecular Probes, 10 µl of a 100 µM solution in a total volume of 1 ml) and incubated for 7 min at room temperature. In the presence of intracellular ROS, dihydroxyrhodamine 123 is transformed to green-fluorescent rhodamine 123, trapped intracellularly. Serum-free treated cells contained E 2 at a concentration of 10 , and horseradish peroxidaseconjugated anti-rabbit IgG (Immunotech), and then exposed to Kodak X-Omat AR films. A PCbased image analysis program was used to quantify the intensity of each band (Image Analysis, Inc., Ontario, Canada). The intensity of the bands was quantified using the Bio-Rad imaging system, and the quantity of the phosphorylated proteins was expressed as the ratio of the phosphorylated divided by the total protein in each case (27, 28) .
Immunoflueroscence localization of membrane estrogen receptors on rat brain slices
Brains of adult male rats were fixed in formalin, immediately after dissection. They were then imbedded in paraffin. A set of three serial sections, 3 µm thick, were cut from each paraffin block, and taken independently on 3 negatively charged (SuperFrost Plus) slides (Kindler O GmbH, Freiburg, Germany). The first two slides were heated at 42.5°C for 20 h to achieve a mild melting of paraffin. After dewaxing in xylene, and rehydration of tissues in decreasing concentrations of ethanol, specimens were washed in distilled water for 20 min and were incubated at 37°C in a citrate buffer 0.01 M (pH 6.2) for 2 h. Afterwards, they were transferred in Tris-buffered saline (TBS, 10 mM, 150 mM NaCl, pH 7. 
RESULTS
Effect of estrogen on serum-deprivation induced apoptosis
Incubation of serum-deprived PC12 cells with E 2 for 24 h resulted in a complete prevention of apoptosis (Fig. 1) . The apoptotic effect was dose related (Fig. 1A) with an IC 50 of 2.4 ± 0.5 nM. The specific ER antagonist ICI 182780 (which had no effect per se) partially inhibited the effect of estradiol, which exhibited an IC 50 of 18.7 ± 3.8 nM. This effect was also shown by using E 2 -BSA, the nonpermeable analog of E 2 and was comparable in potency but was not inhibited by the ICI 182780 analog (IC 50 23.1±2.9 nM and 18.3±4.5 nM in the absence and the presence of ICI 182780 respectively, Fig. 1B) , suggesting that the major cytoprotective action of E 2 in serum-starved PC12 cells apoptosis may be mediated through a membrane action. BSA, on the other hand, at the same concentration range, had no effect in preventing apoptosis of PC12 cells (data not shown). In view of these results, in further experiments we have used a fixed concentration of steroids five times higher than the observed IC 50 of the nonpermeable analog estradiol-BSA (100 nM). Under these conditions, our results, presented in Fig. 1C , show that the effect of E 2 and E 2 -BSA were comparable in potency to this observed with serum supplementation. In contrast, no antiapoptotic effect was found with progesterone and testosterone (Fig. 1D) . The antiapoptotic effect of E 2 and its nonpermeable analog E 2 -BSA was also verified with the detection of cytoplasmic nucleosomes derived by DNA fragmentation (Fig.  1E ) and with flow cytometry of anexin V-propidium iodide stained cells (Fig. 1F) with similar results.
The effect of E 2 is not due to its antioxidant capacity
Estradiol at high concentrations possesses antioxidant activity. To determine whether the observed antiapoptotic effect of E 2 was due to its antioxidant capacity, we have measured the ROS production in serum-deprived PC12 cells cultured in the absence or the presence of steroids. As shown in Fig. 2 , testosterone and progesterone at 10 −7 M (which were ineffective in protecting from apoptosis) exhibited a significant antioxidant activity (10-min ROS-positive cells 9 and 12% respectively, as compared with 51% ROS-positive cells in serum-free conditions, P<0.001), while the anti-apoptotic E 2 , at the same concentration, showed a much lesser reduction of ROS scavenging (30% ROS-positive cells, P<0.01 as compared with serum-free condition, and P<0.01 as compared with testosterone and progesterone). These findings suggest that, at least at the concentrations and the experimental conditions used, the antiapoptotic action of E 2 cannot be attributed to its antioxidant capacity.
Detection of intracellular steroid receptors in PC12 cells
We have shown (Fig. 1 ) that the pure antiestrogen ICI 182780 had a minor but significant effect in reversing the antiapoptotic effect of E 2 . Thus, we have investigated whether ER were implied in these phenomenon. Saturation binding experiments in PC12 cells revealed the presence of low concentrations of estrogen receptors (52,500 sites/cell, K d 4.7±0.9 nM; Fig. 3A ). Only estrogen can bind to these receptors, while progesterone and androgen were ineffective in displacing radiolabeled estradiol. In contract, no specific binding was found for progesterone and androgens (data not shown). Immunocytochemistry with an antibody directed against the N-terminal of the ER (Fig. 3B ) revealed cytoplasmic and nuclear staining of PC12 cells for ER.
An alternative explanation of the ER data presented above could be E 2 binding to the Arylhydrocarbon receptor (AhR). Indeed, this intracellular site can bind estrogen through heterodimerization of AhR receptor with the ER (29) . Although the classical view of AhR-ER interactions is based on a transcriptional competition (30), we have investigated the possible competition of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and estradiol. Our results (Fig. 3C) showed that TCDD completely displaced radiolabeled estradiol, indicating that TCDD could bind to estrogen receptors in PC12 cells. The absence of AhR in this cell line was confirmed by the absence of ethoxyresorufin-and methoxyresorufin-O-deethylase (EROD and MROD) activity of CYP1A1 activity of CYP1A2, a target of AhR activation. No activity was found in either basal or TCDD-treated PC12 cells (Fig. 3D) , indicating that most probable AhR is not expressed in PC12 cells. It thus appears that TCDD binds to ER and that the observed E 2 binding might be attributed to the presence of native ER in these cells. As presented in Fig. 3E , TCDD per se had no cytoprotective activity. In addition, it decreased significantly the cytoprotective action of E 2 and E 2 -BSA, indicating that this agent might be an antagonist of ER or of ERmediated activity.
Detection of membrane steroid receptors
Membrane binding studies Figure 4A depicts the results of binding experiments of tritiated estradiol on PC12 cell membrane preparations. To minimize any interaction with intracellular ER, we have briefly acidified membrane preparations before binding, a method previously used in other systems, to detach adsorbed molecules on membranes (23) . Progesterone and testosterone did not show any specific binding, indicating the absence of membrane sites for these classes of steroid hormones. The detected sites were of high affinity for the homologous ligand E 2 (K d =10.55 nM, binding capacity 279.4 fmol/mg protein). The selectivity of binding, presented also in Fig. 4A , indicates that heterologous steroids present an at least 100-times lower affinity than the homologous ligand (IC 50 for estradiol, progesterone and testosterone 10.55 nM and >10 −6 M, respectively).
Flow cytometry-confocal microscopy
The existence of membrane sites for estradiol was further confirmed by the use of fluorescent analogs of the hormone bound to BSA. These conjugates cannot enter the cell and therefore are used for the identification of membrane hormone binding. Figure 4B reveals the existence of a specific binding of estradiol-BSA on membranes of PC12 cells, by flow cytometry. This binding is specific, compared with the binding of fluorescent-labeled BSA (Fig. 4B) , and saturable. Indeed, the coincubation of cells with a 100-fold molar excess of the homologous ligand completely cleared the specific fluorescence (not shown). As reported previously for prostate cancer cells (31) , the binding of estradiol-BSA on the membranes of PC12 cells was very rapid, and the plateau was reached at 10 min. The membrane localization of estradiol-BSA binding was confirmed by confocal laser microscopy ( Fig. 4C) . It is interesting to note that BSA-FITC did not show any staining of PC12 cells.
Calcium flow
It is now well established that activation of membrane steroid sites results in an increase of intracellular calcium levels (32) , an event strongly related to neuronal and endocrine cell apoptosis in various systems (33) . Results on E 2 modification of intracellular calcium concentrations in our system are presented in Fig. 4D : a substantial increase of intracellular calcium is observed 120 s after application of estrogen.
Early signaling effects occurring after membrane estrogen binding
Calcium
As shown in Fig. 5A , addition of the pure antiestrogen ICI 182780 did not produce any effect on Ca 2+ flow in PC12 cells. In addition it did not modify the rise of intracellular calcium, induced by estrogen (compare Fig. 5A and 4D) . Furthermore, intracellular stores of Ca 2+ are involved in the rapid increase of intracellular calcium induced by estrogen, since a comparable increase of Ca 2+ was observed after E 2 application in cells incubated in a Ca-free medium (Fig. 5B) .
Signaling molecules
A number of Ca
2+
-related intracellular signaling molecules have been tested in PC12 cells, after the application of E 2 . As shown in Fig. 6A , the rise of intracellular Ca 2+ at 2 min was followed by a transient increase of phosphorylated PI3K at 5 min. This rise was followed (at 10 min) by an increased phosphorylation of PKB/Akt, returning to basal levels after 30 min (Fig. 6B) . ICI 182780 did not affect these early effects, indicating that, at least in early stages of E 2 actions, antiestrogens did not antagonize its effect. Addition of the PI3K/Akt inhibitor wortmannin reversed the effect of E 2 and E 2 -BSA on apoptosis (Fig. 6D) , indicating that indeed this pathway is most probably involved in the antiapoptotic effect of estradiol.
Akt phosphorylation/activation results in NOS activation in many systems (34, 35) . This was the case for E 2 in serum-starved PC12 cells too. Indeed, a delayed increase of NOS activity was observed, after the Akt wave, with a maximum at 20 min (Fig. 6B) . These findings considered together suggest the following sequence of events occurring at early stages of E 2 action on serum-starved PC12 cells: Ca 2+ mobilization→PI3K activation→Akt phosplorylation→NOS activation, non-inhibited by antiestrogens. Figure 6C presents a further analysis of NOS activation. As shown, both major NOS isoforms were activated after E 2 treatment. Indeed, preincubation of PC12 cells with the specific antagonists L-NAME (inhibiting predominantly membrane-bound endothelial and neuronal NOS, eNOS and nNOS, respectively) or AMT (inhibiting predominantly iNOS) resulted in partial and complete inhibition of the 20 min, E 2 -induced NOS activation (Fig. 6C) . In addition, preincubation of cells with high concentrations (2 mM) of L-NAME (inhibitory for both isoforms of NOS) completely reversed the antiapoptotic effects of E 2 , indicating that NOS activation and concomitant NO increase might be an important mechanism of E 2 neuroprotection in serum-starved PC12 cells (Fig. 6E) . Figure 7 depicts the detection of membrane estrogen receptors in the hippocampal region of male rat brains, suggesting that estradiol might act as a cytoprotective factor via membrane binding sites not only in PC12 cells but also in the brain.
Detection of membrane estrogen receptors in rat brain
DISCUSSION
Estrogens are pleiotropic factors for the brain. In addition to their long-known endocrine and neuroendocrine effects, their presence, as well as the presence of ER, has been discovered in a number of CNS structures (36) . As the majority of E 2 effects in the CNS are stimulatory and beneficial for cell survival, several studies have proposed estrogens as neuroprotective factors (reviewed in ref 1).
Nevertheless, the mechanism(s) of neuroprotective action of estrogen remain speculative, due most probably to the complexity of the CNS per se. This is the reason for which simpler models have been proposed, to identify and characterize the underlying mechanisms of its neuroprotective properties. These systems include established cell lines from a number of brain regions and species, as well as the PC12 adrenomedullary cell line. Indeed, adrenal medulla derives from neuronal crest and is an integral component of the sympathetic nervous system, expressing a mixed neuronal-epithelioid phenotype. It has been extensively used as a model in the study of sympathetic nervous system physiology, by different groups including ours (14) . We have therefore used this model to study the neuroprotective role of estrogen, using the welldescribed serum-deprivation manipulation to challenge cell survival.
Serum-deprivation results in induction of apoptosis. E 2 specifically reversed apoptosis in a receptor-mediated manner, since other steroids were ineffective. Indeed, testosterone and progesterone were both ineffective in rescuing serum-deprived PC12 cells. The cytoprotective effect of E 2 was not reversed by the pure ER antagonist ICI 182870, suggesting that most probably intracellular ER do not mediate this action. In the present study, we reported the expression of estrogen-specific membrane binding sites on PC12 cells. Accumulating evidence suggests a complementary mechanism of steroid action, different from the classical one, occurring rapidly via steroid receptors located on the cell membrane in both intracellular receptors negative and positive cells (37) (38) (39) . Steroid hormones are shown to elicit rapid induction of intracellular Ca 2+ levels (32) within seconds, due to a significant release of Ca 2+ from intracellular Ca 2+ stores or to the import of extracellular Ca 2+ through Ca 2+ channels (see ref 8 , for a recent review). These actions led to the identification of membrane binding sites (by the use of protein-bound steroids or by binding experiments on membrane preparations) for all steroid hormones, in a variety of cell lines. We had previously identified such binding sites for androgens in a prostate cancer cell line (40) . They are preferentially expressed in cancer cells (31) and induce rapid cytoskeletal changes trough the activation of a specific signaling cascade (41), while after long-term activation they induce apoptosis (Kampa et al., unpublished observations). Recently, Chen et al. (42) reported the activation of membrane-bound guanylate cyclase by estradiol in PC12 membrane preparations. We have thus tested the presence in our system of estrogen membrane binding sites, using a variety of methods. In the present study, estrogen membrane binding was shown with radioligand binding assays, flow cytometry, and confocal laser microscopy of E 2 -BSA-FITC. This site is specific for estrogen, as progesterone and testosterone did not displace radiolabeled E 2 . These findings reveal for the first time the presence of specific E 2 membrane binding on PC12 cells. Our data are supported by a recent report showing guanylate cyclase stimulation by E 2 , implicating a GPCR-related mechanism of action (42) .
Although estrogen membrane binding has been reported by a number of groups, its exact nature is still unknown. Indeed, three different hypotheses are under discussion: 1) this binding is due to a specific membrane site, 2) classical ER bound/trapped in the membrane could interact with the ligand, or finally 3) the steroid could interact with signaling molecules bound or found to the vicinity of the plasma membrane. The first type of action generates signaling phenomena unaffected by antiestrogen, while pure antiestrogenic substances effectively block the later two mechanisms. Binding or adsorption of soluble ER or SHBG binding on membrane preparations was excluded by the use of membrane acidification before binding (23) , while antiestrogen did not antagonize the effect of E 2 , indicating, according to the previous discussion, the presence of a specific E 2 membrane binding site (8, 9, 13) .
To examine the possible postreceptor events after membrane estrogen sites activation, we have investigated the effect of short-term exposure to estradiol on signal transduction pathways, strongly related to cell apoptosis and survival, i.e., calcium mobilization and related activation/phosphorylation of kinases PI3K/Akt. We present evidence that E 2 induce in an antiestrogen-independent manner, Ca 2+ influx in the cytosol and a subsequent rapid activation of PI3K/Akt/NOS system. Indeed, Ca 2+ activation induces PI3K activation, leading to an increase of Akt/NOS activity, in an antiestrogen-independent manner. It is interesting to note that the early effect of E 2 on Ca 2+ mobilization includes, in addition to the influx of extracellular calcium, an intracellular component, as it is reproduced in a Ca 2+ -free medium. The implication of PI3K and Akt in the neuroprotective action of E 2 is supported by the fact that co-incubation of cells with the PI3K/Akt inhibitor wortmannin completely reverses the antiapoptotic effect of both E 2 and E 2 -BSA, indicating that this pathway might be activated through early membrane E 2 action. In addition, the crucial role of NOS in early effects of E 2 is supported by the fact that NOS inhibitors completely reversed the effect of E 2 on cell apoptosis. PI3K activation after E 2 stimulation has been previously reported in arterial endothelial cells, implicated as a protective factor in the ischemia-reperfusion model (34) , while Ca 2+ flux and PI3K activation have also been considered as pivotal for the integration of nongenomic actions of steroids (9) . Different authors have reported the interaction of E 2 with the Akt/NOS pathway in different systems, including the central nervous system, to explain rapid effects of E 2 , and to provide a possible mechanism of endocrine therapy of human tumors (43) (44) (45) (46) (47) (48) . In addition, a number of authors have reported the rapid activation of eNOS after E 2 application through genomic and nongenomic mechanisms (35) . This action has been proposed to be mediated in caveolae formed after E 2 rapid action (34, 49) and is mediated through intracellular ER, effect inhibited by pure antiestrogens (50) . In our system, estradiol appears to act differently. Indeed, ICI 182780 did not prevent its antiapoptotic action, suggesting that antiestrogen insensitive membrane receptors might be implicated in the phenomenon.
According to the Mannheim criteria (51), a nongenomic effect of steroid hormones [proposed to be named "membrane-initiated steroid signaling" (MISS)] might occur within minutes, being observed in cells not expressing intracellular steroid receptors and being insensitive to inhibitors of transcription and translation (e.g., actinimycin-D and cycloheximide). Furthermore, activation of these membrane binding sites might be triggered by nonpermeable (e.g., BSA-coupled) steroids and, in most cases, is insensitive to steroid antagonists. Nongenomic steroid actions have been reported for all types of steroids (for recent reviews see refs 8, 52) . Although the nature of these membrane steroid sites was elusive until recently, the recent cloning of a membrane progesterone receptor (53) (54) (55) (56) , and the isolation of a glucocorticoid binding protein with homologies with kappa-opioid receptors (57) indicate that these proteins might belong to the seven-transmembrane-G-protein coupled receptors. In this respect, the identified E 2 specific membrane binding component on PC12 cells fulfils the above criteria and can be suggested as a true binding site, mediating the cytoprotective effects of E 2 in this cell line.
The elucidation of the mode of action of estrogens in neural cells represents a major challenge in endocrine pathophysiology. Indeed, E 2 promotes cell survival and differentiation of the fetal and adult brain tissue. In addition, a number of clinical and epidemiological studies involve this hormone as a protective factor in a number of acute (stroke) and chronic neurodegenerative disorders (Alzheimer's disease) and schizophrenia (1). We report here for the first time the existence of E 2 specific membrane binding sites on neuronal-crest derived PC12 cells, strongly related to the cytoprotective action of E 2 , in this system. In addition, the presence of E 2 membrane binding sites in the rat brain, and especially in the hippocampal region, strongly related to memory and senescence, indicates that membrane estrogen binding may also contribute to the protective effects of E 2 in the nervous system. . Early signaling effects of estradiol membrane receptor activation. A) Nongenomic effects of E 2 action in PC12 cells, intracellular Ca 2+ movements and PI3K activation. For the latter, the phosphorylated/nonphosphorylated form of the enzyme was assayed and divided by the same ratio in control (non-E 2 -treated) cells. B) Effect of early E 2 action on PKB/Akt and NOS. The ratio of phosphorylated/nonphosphorylated ration was divided by the same ratio in control (nontreated) cells. For NOS, the enzyme activity in treated/nontreated cells is presented. C) The preincubation of PC12 cells with the NOS inhibitors L-NAME and AMT [inhibiting at low (1 mM) concentrations e/nNOS and iNOS, respectively] revert the 20-min E 2 -induced activation of NOS activity. The pure antiestrogen ICI182780 has no effect on the phenomenon, indicating a nonclassical E 2 action. Data are means ± SE of 2 independent experiments in duplicate. D) Inhibition of PI3K/Akt reverts the effect of E 2 and E 2 -BSA on PC12 cell apoptosis. Preincubation of cells with the specific PI3K/Akt inhibitor wortmannin reverts the antiapoptotic effects of E 2 and E 2 -BSA. Data are means ± SE of 2 experiments in triplicate. *Statistical significance as compared with serum-free conditions (P<0.01). E) Inhibition of NOS activity reverts the antiapoptotic effects of E 2 . Preincubation of cells in the presence of high (2 mM) concentrations of L-NAME inhibits the antiapoptotic effect of 10 −7 M E 2 . Data are means ± SE of 3 experiments. *Statistical significance as compared with serum-free conditions (P<0.01). 7 . Localization of membrane estrogen receptors on rat brain slices. Brains of adult male rats were fixed in formalin, immediately after dissection. They were then imbedded in paraffin, dewaxed in xylene, rehydrated, and incubated for 1 h with E 2 -BSA-FITC 10 −6 M (test slide) or BSA-FITC 10 −6 M (control slide). After being rinsed in TBS for 10 min, slides were washed and viewed in a confocal laser scanning microscope with the same settings (x400). Inset is a greater magnification of the surrounded area (x2520) indicating the membrane localization of fluorescence.
